New Antibody–Drug Conjugates for NSCLC in the Limelight: Expert Guidance on the Integration of TROP-2–Targeting Agents Into Clinical Practice

Gain an in-depth understanding of emerging TROP-2–targeting ADCs with downloadable slidesets and expert reviews and commentaries.

Share

Program Content

Activities

Collaborative Learning on TROP2 ADCs in NSCLC
Tailored Education on TROP-2‒Targeting ADCs in NSCLC: My Reflections on a Small-Group Collaborative Learning Experience
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: February 29, 2024

TROP-2 ADCs in NSCLC
Expert Perspectives on TROP-2–Targeting ADCs for Advanced NSCLC
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: July 15, 2024

Expires: July 14, 2025

Activities

AEs With TROP2 ADCs
Identification and Management of AEs With TROP-2–Targeted ADCs
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: April 04, 2024

Expires: April 03, 2025

AEs With TROP2 ADCs
Identification and Management of Adverse Events With TROP-2–Targeted ADCs
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: April 04, 2024

Expires: April 03, 2025

TROP-2 in NSCLC
TROP-2 Overview in NSCLC: Expression, Significance, and Therapeutic Rationale
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: April 25, 2024

Expires: April 24, 2025

TROP-2 in NSCLC
TROP-2 Overview in NSCLC: Expression, Significance, and Therapeutic Rationale
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: April 25, 2024

Expires: April 24, 2025

TROP2 Targeted Tx in Adv NSCLC
Clinical Landscape of TROP-2–Targeted Therapy in Advanced/Metastatic NSCLC
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: June 24, 2024

Expires: June 23, 2025

TROP2 Targeted Tx in Adv NSCLC
Clinical Landscape of TROP-2–Targeted Therapy in Advanced/Metastatic NSCLC
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: June 21, 2024

Expires: June 20, 2025

TROP 2 Combination Therapy
Novel Combinatorial Approaches With TROP-2–Targeted Therapy in Advanced NSCLC
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: July 10, 2024

Expires: July 09, 2025

TROP 2 Combination Therapy
Novel Combinatorial Approaches With TROP-2–Targeted Therapy in Advanced NSCLC
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 10, 2024

Expires: July 09, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.

AstraZeneca

Daiichi Sankyo, Inc.